Age-dependent decline of blood–brain barrier P-glycoprotein expression in the canine brain
Authors:
- E.L. SchneiderESE.L. Schneider
- W. BaumgärtnerWBW. Baumgärtner
- V.M. SteinVSV.M. Stein
- A. TipoldATA. Tipold
- H. PotschkaHPH. Potschka
- 1 August 2011
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 32 (8) , 1477-1485
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Expression of multi-drug resistance 1 mRNA in human and rodent tissues: reduced levels in Parkinson patientsCell and tissue research, 2008
- Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System PharmacotherapyPharmacological Reviews, 2008
- Seizure-Induced Up-Regulation of P-Glycoprotein at the Blood-Brain Barrier through Glutamate and Cyclooxygenase-2 SignalingMolecular Pharmacology, 2008
- Effect of aging on neurogenesis in the canine brainAging Cell, 2008
- Decreased blood–brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSAJournal of Neural Transmission, 2008
- Monotherapy in adults and elderly personsNeurology, 2007
- Role of drug efflux carriers in the healthy and diseased brainAnnals of Neurology, 2006
- MDR1, the blood–brain barrier transporter, is associated with Parkinson’s disease in ethnic ChineseJournal of Medical Genetics, 2004
- Deposition of Alzheimer's ??-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humansPharmacogenetics, 2002
- Drug Dosage in the ElderlyDrugs & Aging, 1998